How much do we really know about the microbiome? What does it take to identify new probiotic strains and their associated health benefits? When should we leverage precise single strains and when is it more effective to use synergistic blends?
I am grateful to talk again with the brilliant scientist and incredibly courageous entrepreneur, Dr. Colleen Cutcliffe. Colleen has over 20 years experience managing and leading teams in biotech, pharma, and academia — I just love picking her brilliant brain! She completed her postdoc research at Northwestern’s Children’s Memorial Hospital and earned her PhD in biochemistry and molecular biology from Johns Hopkins. In this episode of New Frontiers, we explore novel probiotic strains such as Clostridium buytricum, Clostridium beijerinckii & Anaerobutyricum hallii, discuss their synergy in producing short-chain fatty acids and potential to stimulate satiety-inducing GLP-1, and so much more!
I commend Colleen and the team at Pendulum for their dedication to bringing new & challenging science and next-generation probiotics to the world. I sure learned a lot, and am sure you will, too. Let me know with a comment, review, and rating wherever you listen to New Frontiers! ~DrKF
Dr. Kara Fitzgerald | New Frontiers in Functional Medicine, Longevity, Epigenetics